Kang-Quan Hu Selected Research

Cryptoxanthins

1/2020	Xanthophyll β-Cryptoxanthin Inhibits Highly Refined Carbohydrate Diet-Promoted Hepatocellular Carcinoma Progression in Mice.
1/2019	Dietary β-Cryptoxanthin Inhibits High-Refined Carbohydrate Diet-Induced Fatty Liver via Differential Protective Mechanisms Depending on Carotenoid Cleavage Enzymes in Male Mice.
11/2016	β-Cryptoxanthin Reduced Lung Tumor Multiplicity and Inhibited Lung Cancer Cell Motility by Downregulating Nicotinic Acetylcholine Receptor α7 Signaling.
4/2013	β-cryptoxanthin restores nicotine-reduced lung SIRT1 to normal levels and inhibits nicotine-promoted lung tumorigenesis and emphysema in A/J mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kang-Quan Hu Research Topics

Disease

11	Neoplasms (Cancer) 01/2020 - 06/2003
5	Carcinogenesis 01/2020 - 04/2013
5	Inflammation (Inflammations) 12/2018 - 12/2013
5	Lung Neoplasms (Lung Cancer) 01/2018 - 11/2006
3	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 01/2016
3	Non-alcoholic Fatty Liver Disease 01/2019 - 01/2016
2	Body Weight (Weight, Body) 01/2020 - 11/2015
2	Fatty Liver 01/2019 - 01/2016
1	Hypoxia (Hypoxemia) 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Liver Neoplasms (Liver Cancer) 01/2016
1	Alcoholic Fatty Liver 01/2016
1	Adenoma (Adenomas) 11/2015
1	Glucose Intolerance 12/2013
1	Emphysema 04/2013
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2006
1	Neuroblastoma 01/2006

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2006
5	LycopeneIBA 12/2018 - 12/2013
4	CryptoxanthinsIBA 01/2020 - 04/2013
4	CarbohydratesIBA 01/2020 - 11/2015
4	Carotenoids (Carotene)IBA 01/2019 - 11/2016
4	Sirtuin 1IBA 01/2018 - 04/2013
4	Messenger RNA (mRNA)IBA 11/2016 - 11/2006
3	EnzymesIBA 01/2019 - 01/2018
2	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2020 - 12/2013
2	ProvitaminsIBA 01/2019 - 11/2016
2	PowdersIBA 12/2018 - 01/2018
2	apo-10'-lycopenoic acidIBA 01/2018 - 12/2013
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 11/2016 - 12/2013
2	CarcinogensIBA 01/2016 - 12/2013
2	InterleukinsIBA 12/2013 - 04/2013
2	SmokeIBA 12/2013 - 04/2013
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2020
1	Vitamin A (Retinol)FDA LinkGeneric 01/2019
1	AdiponectinIBA 01/2018
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2018
1	BilirubinIBA 01/2016
1	Steroid 12-alpha-Hydroxylase (CYP8B1)IBA 11/2015
1	CholesterolIBA 11/2015
1	Fatty Acids (Saturated Fatty Acids)IBA 11/2015
1	Nicotinamide PhosphoribosyltransferaseIBA 11/2015
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 11/2015
1	NAD (NADH)IBA 12/2013
1	Biomarkers (Surrogate Marker)IBA 12/2013
1	Nicotine FDA Link 04/2013
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 04/2013
1	Beta-CryptoxanthinIBA 11/2006
1	Cyclin EIBA 11/2006
1	Cyclin D1IBA 11/2006
1	retinoic acid receptor betaIBA 11/2006
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2004
1	beta CateninIBA 06/2003

Therapy/Procedure

1	Intraperitoneal Injections 01/2020